Corrigendum to “Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: 9 Years’ Follow-up of DEFINE, CONFIRM, and ENDORSE”

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842109/
https://www.ncbi.nlm.nih.gov/pubmed/35173806
http://dx.doi.org/10.1177/1756286420968357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842109/
https://www.ncbi.nlm.nih.gov/pubmed/35173806
http://dx.doi.org/10.1177/1756286420968357

Ejemplares similares